P450, cytochrome P450 monooxygenase; Vdh, vitamin D 3 hydroxylase; VD 3 , vitamin D 3 ; 25(OH)VD 3 , 25-hydroxyvitamin D 3 ; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis; PMCD, partially methylated-β-cyclodextrin; NADH, β-nicotinamide adenine dinucleotide, reduced form; HPLC, high-performance liquid chromatography; GCCD, green chemiluminescent cyclodextrin.
Introduction
Vitamin D 3 (VD 3 ) is a fat-soluble prohormone in mammals that plays a crucial role in bone metabolism, immunity, and the control of cell proliferation and differentiation. VD 3 is obtained from food or is produced in skin when 7-dehydrocholesterol reacts with ultraviolet-B light from the sun or artificial sources [1, 2] . In mammalians, VD 3 is hydroxylated by cytochrome P450 in the liver at the C-25 position forming 25-hydroxyvitamin D 3 (25(OH)VD 3 ); it is subsequently hydroxylated by another P450 in the kidneys at the C-1α position forming 1α,25-dihydroxyvitamin D 3 (1α,25(OH) 2 VD 3 ). The most active form, 1α,25(OH) 2 VD 3 , is used to treat osteoporosis, hyperparathyroidism, psoriasis, and VD 3 metabolic abnormality. The industrial production of 1α,25(OH) 2 VD 3 is performed chemically or microbiologically. The processes for the microbiological production of the active form of VD 3 are simpler than those for chemical synthesis.
variety of guest molecules, including poorly water-soluble compounds, to form noncovalent inclusion complexes [6] . The complexation of progesterone with hydroxypropyl-β-cyclodextrin enhances androstadienedione production during bioconversion [7] . PMCD is a partially methylated-β-cyclodextrin that immobilizes VD 3 and its hydroxylated forms in its inner hydrophobic cavity. Consequently, the solubility of VD 3 in water is drastically increased (640 µg VD 3 /ml, 1.5% PMCD); this improved solubility facilitates the hydroxylase activity of Vdh [8] .
The conversion rate of VD 3 to its hydroxylated forms in a cell-free assay is much higher than that in in vivo experiments [3, 8] ; this suggests that the low transport rates of VD 3 and its hydroxylated forms to and from cells are the rate-limiting steps in its bioconversion processes.
Nisin is a small antimicrobial peptide composed of 34 amino acids that are produced by Lactococcus lactis subsp. lactis. Nisin is highly effective against a range of gram-positive bacteria, including food-borne pathogens such as Listeria monocytogenes and Clostridium botulinum [9] . Its status is "generally recognized as safe", and is used as a food biopreservative in more than 50 countries [10] . It exerts its biocidal activity via both pore formation in the membrane and the disruption of cell wall biosynthesis by binding to lipid II, which is an essential intermediate in peptidoglycan biogenesis. The pore structure is made up of 4 lipid II and 8 nisin molecules [11] . Previous studies demonstrate that nisin inhibits the growth of the actinomycetes Mycobacterium smegmatis and M. tuberculosis, by forming pores, which leads to proton motive force dissipation and the efflux of many vital intracellular compounds [12, 13] .
In this study, we tested whether the nisin pore complex improves the accessibility of substrate-cyclodextrin complexes to the inside of Rhodococcus cells and enhances 25(OH)VD 3 production from VD 3 via biotransformation. Here, we report a new innovative procedure for enhancing the bioconversion of VD 3 to 25(OH)VD 3 with a recombinant strain of
R. erythropolis.
(Applied Biosystems, CA, USA) on an ABI Prism 3100 automated sequencer (Applied Biosystems Inc., CT, USA) according to the manufacturerʼs instructions.
Construction of expression plasmids
For the construction of expression vectors, pTipQC-vdh, pTipQC-vdh-thcCD, and pTipQC-vdh-aciBC, each gene was amplified by PCR, digested with appropriate restriction enzymes, and introduced into the pTipQC2 vector [17] . Vdh expression levels were determined by reduced-CO difference spectral analysis. The detailed plasmid construction procedure is described in Supplementary Methods.
Structural stability of ThcC and AciB
To express recombinant ThcC and AciB proteins, their corresponding genes were cloned into the NdeI and XhoI sites of pET26b (Novagen, WI, USA). The expression, isolation, and the [2Fe-2S] cluster stability assay of recombinant ThcC and AciB are described in Supplementary Methods.
Determination of nisin sensitivity using the colony count method
To determine the effects of nisin on actively growing R. erythropolis JCM3201 cells, cells cultured overnight were diluted in LB broth to an OD 600 of 5.0 and were divided into 15-ml aliquots [12] . The cells were exposed to different concentration of nisin (0, 0.25, 0.5, 1.0, or 2.0 mg/ml; Sigma-Aldrich Co., MO, USA) and were incubated for 1-10 h at 28 °C under constant agitation. Cultured cells (100 μl) were plated onto LB agar without antibiotics, incubated for 3 days at 28 °C, and enumerated.
Permeability assay of cyclodextrin to cytosol in nisin-treated cells
To determine the effects of nisin on the permeability of cyclodextrin to the cytoplasm of R. erythropolis cells, green chemiluminescent cyclodextrin (GCCD) (Wako Pure Chemical Industries Ltd., Osaka, Japan) [18] was used as a model substrate; GCCD in the cytoplasm was detected using superoxide-induced chemiluminescence intensity as described in Supplementary Methods.
Expression and isolation of recombinant GlcDH-IV
To express recombinant glucose dehydrogenase from Bacillus megaterium IAM1030 (GlcDH-IV), its corresponding gene was cloned into the NdeI and XhoI sites of pET28a (Novagen) [19] . The expression and isolation of recombinant GlcDH-IV is described in the Supplementary Methods.
Repeated bioconversion of vitamin D 3 using nisin-treated Rhodococcus erythropolis
Two cell strains, JCM3201/pTipQC-vdh-thcCD and JCM3201/pTipQC-vdh-aciBC, were prepared and independently cultured; their VD 3 bioconversion activities were measured in the presence or absence of nisin. The reaction solution containing 1 mM VD 3 was refreshed every 16 h, and 4 consecutive reactions were performed. Vitamin D 3 metabolites were determined on the basis of the bioconversion rate of inactive vitamin D 3 into its hydroxylated active form as described previously [3, 5] . The reconstitution system of NADH (2% glucose, 2 U/ml GlcDH-IV, and 4 mM NADH) was used for the bioconversion of VD 3 to 25(OH)VD 3 in nisin-treated cells. The detailed experimental procedure is described in Supplementary Methods.
Results and discussion

Permeability of cyclodextrin to cytosol in nisin-treated Rhodococcus erythropolis cells
We first determined the effects of a small antimicrobial protein, nisin, on the growth of R. erythropolis JCM3201. The nisin-resistant cells decreased in a dose-dependent manner: 1% residual R. erythropolis cells with 0.25 mg/ml nisin (Fig. 1A) . The sensitivity of R. erythropolis to nisin is slightly lower than that of M. smegmatis [12] . No apparent cell lysis was observed after 5 h incubation with 0.4 mg/ml nisin, and no proteins were detected in the extracellular media by SDS-PAGE (data not shown). It is reported that nisin forms pores with the cell wall precursor lipid II that have diameters of 2 to 2.5 nm [20] . It may be possible that nisin pores function as open channels for the passage of VD 3 -PMCD complexes. Then, we investigated whether cyclodextrin can be transported into the cytoplasmic space after cells are treated with nisin. For this purpose, GCCD was used as a model substrate and was detected by the superoxide-induced chemiluminescence intensity as described in Materials and methods. The GCCD luminescence intensity in the cytoplasmic space increased in the presence of nisin in a dose-dependent manner; the maximum luminescence intensity ranged between 0.25 and 1.0 mg/ml nisin. Meanwhile, almost no GCCD was detected in the cell extracts without nisin treatment (Fig. 1B) , suggesting that VD 3 is released from PMCD and is transported to the cytoplasmic space by diffusion in in vivo VD 3 biotransformation experiments. Since the accumulation of GCCD in the cytoplasmic space increased in a time-dependent manner and required over 3 h to reach equilibrium, nisin continuously formed cell membrane pore complexes (Fig. 1C) . GCCD is a γ-CD-modified probe; the dimensions of γ-CD (0.78 nm high × 1.69 nm outer diameter) are smaller than those of nisin pores [6] .
Taken together, these results demonstrate that nisin inhibits R. erythropolis growth and increases the permeability of GCCD into the cytoplasmic space, possibly by forming nisin-lipid II pore complexes in the membrane.
NADH regeneration system enhances 25(OH)VD 3 production in nisin-treated cells
To clarify whether nisin enhances the bioconversion of VD 3 to 25(OH)VD 3 , the cell strain (JCM3201/pTipQC-vdh-thcCD) coexpressing Vdh and redox partner proteins, ThcC and ThcD from R. erythropolis NI86/21, was prepared and incubated with VD 3 -PMCD complexes in the presence or absence of nisin ( Fig. 2A) . Protein expression increased in the presence of thiostrepton in a dose-dependent manner, but 25(OH)VD 3 production was not enhanced in any thiostrepton-treated cells when nisin was absent. However, in the presence of nisin, the cells exhibited an increased (up to 3.9-fold) conversion rate of VD 3 to 25(OH)VD 3 that was correlated with the expression levels of the proteins. These data suggest that nisin enhances the transport of VD 3 -PMCD complexes to the cytoplasm and increases the concentration of VD 3 in the intracellular space. For nisin-treated cells, an electron donor, NADH, and its regeneration system, which is composed of glucose and glucose dehydrogenase from Bacillus megaterium IAM1030 (GlcDH-IV) strongly supported Vdh activity. ThcD is an NADH-dependent ferredoxin reductase (Fig. 2B ). When JCM3201/pTipQC-vdh-thcCD cells were treated with different concentrations of nisin (0-1.0 mg/ml), a time-dependent increase in 25(OH)VD 3 production was observed in the presence of the NADH-regenerating system. Approximately 50% of VD 3 was hydroxylated after a 16-h reaction with 0.75-1.0 mg/ml nisin, while only 13.8% was hydroxylated in the absence of nisin (Fig. 2C) . The highest conversion rate of VD 3 was achieved in the cells treated with 1 mg/ml nisin (52.5% after 24-h reaction). These results indicate that the NADH-regeneration system is essential for enhancing the bioconversion of VD 3 to 25(OH)VD 3 . Increases in the NADH pool may facilitate electron transfer from ferredoxin (ThcC) to Vdh.
Co-expression of Vdh and redox partner proteins
P450s generally require the sequential delivery of 2 electrons passed from redox partner proteins to facilitate its monooxygenase activity. In the case of Vdh, it is reported that in addition to ThcCD from R. erythropolis NI86/21 another exogenous redox partner, AciBC from Acinetobacter sp. OC4, provides efficient electron transfer to the heme iron of Vdh [3, 21] . Both AciB and ThcC are [2Fe-2S] cluster containing ferredoxins (2Fe-2S ferredoxin); AciB exhibits significant amino acid sequence similarity to ThcC (38.7% identity). ThcD and AciC are ferredoxin reductases; they also show significant amino acid sequence similarity to each other (41.8% identity). To clarify which redox partner protein is a suitable electron transfer system for Vdh, the R. erythropolis strain coexpressing Vdh and AciBC (JCM3201/pTipQC-vdh-aciBC) was prepared, and the biotransformation activity of VD 3 to 25(OH)VD 3 was measured ( SDS-PAGE analysis revealed that the expression levels of ThcC in JCM3201/pTipQC-vdh-thcCD and AciB in JCM3201/pTipQC-vdh-aciBC were different; ThcC was observed as an intense band, while AciB was barely visible (Fig. 3B) . When the degradation of the [2Fe-2S] cluster of recombinant ThcC and AciB was monitored, its degradation in holo-ThcC was much faster than that of holo-AciB; 77% of ThcC is inactivated after a 24-h incubation (Fig. 3C ). Protein synthesis in nisin-treated cells may be disrupted by the efflux of vital intracellular compounds through nisin pores. The structural and functional stability of ferredoxin is therefore critical for the P450-mediated biotransformation process using nisin-treated cells.
Repeated bioconversion of VD 3 to 25-hydoxylated using nisin-treated cells
After the reaction conditions were optimized, the VD 3 hydroxylation activity of JCM3201/pTipQC-vdh-aciBC. In the presence of nisin, the bioconversion rate in JCM3201/pTipQC-vdh-thcCD decreased regardless of reaction time; furthermore, the amount of 25(OH)VD 3 produced in the fourth reaction was less than that produced by the cells without nisin (Fig. 4A ). Since 65% of holo-ThcC is inactivated after a 16-h incubation (Fig. 3C) , the synthesis of ThcC may have stopped; thus, the [2Fe-2S] cluster would not be assembled and transferred to apo-ThcC. In JCM3201/pTipQC-vdh-aciBC cells, VD 3 hydroxylation activity increased after the second reaction (Fig. 4C ). This may be caused by the increased number of nisin pores in the membrane within the first 16 h; the maximum transportation rate of VD 3 -PMCD complexes to the cytoplasm may be attained after at least a 3-h exposure to nisin (Fig. 1C) . The total amount of 25(OH)VD 3 produced in each strain was markedly different: 431.7 versus 1176.5 µg in JCM3201/pTipQC-vdh-thcCD and JCM3201/pTipQC-vdh-aciBC, respectively ( Fig. 4B and D) . Based on the in vitro reconstitution experiment, Vdh and ferredoxin reductases, ThcD and AciC, were structurally and functionally stable (data not shown). Nisin pores are quite stable once formed as reported previously [11] . Taken together, the stable electron transfer from AciB to Vdh was crucial for the bioconversion of VD 3 to 25(OH)VD 3 in this experiment.
Further protein engineering studies of Vdh and redox partner proteins, and cell biological studies using nisin are required to elucidate the molecular mechanisms underlying 
Supplementary Methods
Expression vector construction
To construct the expression vectors pTipQC-vdh, pTipQC-vdh-thcCD, and pTipQC-vdh-aciBC, PCRs were performed using KOD plus DNA polymerase (Toyobo Co., Osaka, Japan). The vdh gene was amplified by PCR using the following primers with pTipQT2-vdh-thcCD as the template [1] : vdh-F, 5′-GGAATTCCATATGGCGCTGACCACCACCGGCACC-3′ (NdeI site is underlined) and vdh-R, 5′-GGAATTCTCAGGCGCTGCGCGGCCCCATC-3′ (EcoRI site is underlined). The PCR fragment was isolated, digested with NdeI and EcoRI, and inserted into the corresponding sites of pTipQC2 [2] , yielding pTipQC-vdh.
The thcCD gene was amplified by PCR using the following primers with pTipQT2-vdh-thcCD as the template: thcC-F, DNA was isolated, digested with EcoRI and SpeI, and cloned into the corresponding sites of pTipQC2-vdh, yielding pTipQC-vdh-thcCD.
The aciB gene was amplified using the following primers: aciB-F, 5′-GGAATTCCATATGGGCCAAATTACATTTATTG-3′ (NdeI site is underlined) and aciB-R, 5′-CCCAAGCTTTTACATCTGAAACTCAGGC-3′ (HindIII site is underlined). The expression vector pNami2vdh (kindly provided by Dr. A. Arisawa, Mercian Corporation) was used as the template. The PCR fragment was isolated, digested with NdeI and HindIII, and cloned into the corresponding sites of pTipQC2, yielding pTipQC2-aciB. The ribosome-binding region derived from pTipQC2 and the aciB gene was amplified by PCR using the following primers with pTipQC2-aciB as the template:
LG10RBS_E-F, 5′-GGAATTCCTCTAGAAATAATTTTGTTTAAC-3′ (EcoRI site is underlined) and aciB-R, 5′-CCCAAGCTTTTACATCTGAAACTCAGGC-3′ (HindIII site is underlined). Amplified DNA was isolated, digested with EcoRI and HindIII, and cloned into the corresponding sites of pTipQC2-vdh, yielding pTipQC2-vdh-aciB.
The aciC gene was amplified by PCR using the following primers with pNami2vdh as the template: aciC-F, 5′-GGAATTCCATATGCAAACAATCGTCATCATTG-3′ (NdeI site is underlined) and aciC-R, 5′-GACTAGTCTACCCCATCAACGCCTGTAC-3′ (SpeI site is underlined). The PCR fragment was isolated, digested with NdeI and SpeI, and inserted into the corresponding sites of pTipQC2, yielding pTipQC2-aciC. The ribosome-binding region derived from pTipQC2 and aciC gene was amplified by PCR using the following primers with pTipQC2-aciB as the template:
LG10RBS_H-F,
Expression and purification of the recombinant ferredoxins
To express the ThcC and AciB proteins, their corresponding genes were cloned into the NdeI and XhoI sites of pET26b (Novagen, WI, USA).
The gene encoding thcC (gene bank accession number U17130) was amplified by PCR using Pfu Turbo DNA polymerase (Stratagene, CA, USA) with the following primers:
thcC-F, 5′-GGGAATTCCATATGCCTACCGTCACCTACGTTCAC-3′ (NdeI site is underlined) and thcC-R, 5′-CGCTCGAGTCATACTTGCTCCTCCGGAAGCCGG-3′ (XhoI site is underlined). The R. erythropolis NI86/21 genome DNA was used as the template.
The gene encoding aciB from Acinetobacter sp. OC4 (gene bank accession number AB221118) was amplified by PCR using the following primers: aciB-F, 5′-GGAATTCCATATGGGCCAAATTACATTTATTG-3′ (NdeI site is underlined) and aciB-R, 5′-CGCTCGAGTTACATCTGAAACTCAGGCAGA-3′ (XhoI site is underlined). The expression vector pNami2vdh was used as the template.
Transformed E.coli BL21-CodonPlus(DE3)-RIL cells were grown at 37 °C in 100 ml LB medium supplemented with 20 µg/ml kanamycin and 34 µg/ml chloramphenicol.
This culture was then inoculated at a ratio of 100 ml overnight cultures into 900 ml LB medium.
Expression was induced by the addition of 0.1 mM IPTG (isopropyl-β-D-thiogalactoside), and the culture was incubated overnight at 25 °C.
The cells were harvested from the culture by centrifugation at 3,000 × g for 10 min.
The cell pellet was resuspended in Buffer A (50 mM Tris-HCl, 100 mM NaCl, and 1 mM DTT; Ferredoxin concentrations were estimated as described previously with minor modifications [3] . The sample in 100 mM Tris-HCl (pH 8. Fifteen micrograms of the protein from each clone was loaded onto a 12.5% SDS-PAGE gel, followed by staining with Coomassie brilliant blue G-250. The concentration of Vdh was determined by reduced-CO difference spectral analysis [5] .
Expression and purification of the recombinant GlcDH-IV
To express recombinant GlcDH-IV with N-terminal His tags, the corresponding gene (gene bank accession number D10626) was cloned into the NdeI and XhoI sites of pET28a (Novagen) [6] . E.coli BL21-CodonPlus(DE3)-RIL cells were grown at 37 °C in 100 ml LB medium supplemented with 20 µg/ml kanamycin and 34 µg/ml chloramphenicol. This culture was then inoculated at a ratio of 100 ml overnight cultures to 900 ml LB medium. The expression was induced by the addition of 0.4 mM IPTG, and the culture was incubated overnight at 30 °C.
Bacillus megaterium IAM1030 has 4GlcDH isozymes (I-IV
The cells were harvested from the culture by centrifugation at 3,000 × g for 10 min. The cell pellet was resuspended in Buffer C containing 1 mg/ml lysozyme and about 50 U/ml benzonase. The cell suspension was incubated on ice for 30 min and sonicated for a few minutes. After centrifugation at 27,200 × g for 20 min, the supernatant was loaded onto a Ni-affinity column (HIS-SELECT resin; Sigma-Aldrich Co.) equilibrated with Buffer C. Bound proteins were washed with Buffer D (50 mM sodium phosphate, 300 mM NaCl, and 10% glycerol; pH 6.0) and eluted using a linear gradient of 0-0.4 M imidazole in Buffer D.
Enzymatic activity was assayed as described previously [7] .
The purified fractions were pooled and dialyzed against a 25 mM Tris-HCl and 20%
glycerol (pH 7.5), and stored at -20 °C.
HPLC analysis of vitamin D 3 metabolites produced in recombinant Rhodococcus erythropolis cells
The vitamin D 3 metabolites were determined on the basis of the bioconversion rate of inactive vitamin D 3 into its hydroxylated active form as described previously [1, 8] . In brief, 24 h after the addition of thiostrepton, the cell pellet was washed twice with 50 mM potassium phosphate buffer (pH 7.4), resuspended in 50 mM potassium phosphate buffer (pH 7.4) containing 0.5 mM vitamin D 3 (Sigma-Aldrich Co.) as a substrate, 0.5% methyl-β-cyclodextrin (PMCD; Junsei Chemical Co. Ltd., Tokyo, Japan), 10 % glycerol, 1 mM thiamine, nisin (0, 0.25, 0.5, 0.75, or 1.0 mg/ml), and the reconstitution system of NADH (2% glucose, 2 U/ml GlcDH-IV, and 4 mM NADH)(OD 600 = 5.0). The bioconversion was performed by incubating the reaction mixture at 28 °C for 8, 16, or 24 h. The mixture was then centrifuged at 20,800 × g for 10 min at 4 °C, and 100 µl from the supernatant was mixed with 900 µl methanol and centrifuged again for 10 min at the same speed and temperature. The methanol solution was analyzed by HPLC equipped with a Jʼsphere ODS-H80 (75 mm × 4.6 mm internal diameter; YMC Co., Ltd., Kyoto, Japan) controlled at a column temperature of 40 °C. Samples were resolved on the column using a linear gradient of 70% to 85% methanol for 10.1 min, 85% to 100% methanol for 0.3 min, 100% methanol for 7.2 min, 100% to 70% methanol for 0.8 min, and 70% methanol for 1.6 min at a flow rate of 1.0 ml/min. The metabolites were detected by UV-monitoring at 265 nm. 25(OH)VD 3 and VD 3 had retention times of 13.5 min and 17.8 min, respectively.
Repeated VD 3 bioconversion using recombinant Rhodococcus erythropolis cells
Two cell strains (JCM3201/pTipQC-vdh-thcCD and JCM3201/pTipQC-vdh-aciBC) co-expressing Vdh and its redox partner proteins, ThcC and ThcD or AciB and AciC, were constructed. To determine of the effects of the reuse of nisin-treated cells for vitamin D 3 conversion, 24 h after the addition of thiostrepton, the cell pellet was washed twice with 50 mM potassium phosphate buffer (pH 7.4) and was resuspended in 50 mM potassium phosphate buffer (pH 7.4) containing 2% glucose, 10% glycerol, 0.5% methyl-β-cyclodextrin, 1 mM thiamine, 1.0 mM vitamin D 3 as a substrate, 0 or 0.5 mg/ml nisin, 2 U/ml GlcDH-IV, and 4 mM NADH to obtain an OD 600 of 5.0. The bioconversion was performed by incubating the reaction solution at 28 °C for 16 h with agitation. The reaction solution (without nisin) was refreshed every 16 h, and 4 consecutive reactions (about 64 h in total) were performed. The mixture was then centrifuged at 20,800 × g for 10 min at 4 °C, and 100 µl from the supernatant was mixed with 900 µl methanol and centrifuged again for 10 min at the same speed and temperature. These respective methanol solutions were analyzed by HPLC.
Assay for determination of protein concentration
Protein concentrations of crude extract and recombinant GlcDH-IV were determined using the Bradford assay with bovine serum albumin (BSA) as the standard [9] .
